Bulgaricus) was demonstrated as an effective therapy in both murine IL-10−/− colitis (Jijon et al., 2004) and trinitrobenzenesulphonic acid (TNBS) induced colitis through enhancement of IL-10 and TGF-β expressing T cells (Di Giacinto et al., 2005). This evidence concerns the gene TGFB1 and colitis.